WHO-GMP Certified Commercial Pack · Product Code: AKP-061
Moxifloxacin 0.5% w/v Eye Drops
Formulation Overview: Preservative-optimized fourth-generation fluoroquinolone sterile eye drops delivering rapid corneal penetration and potent eradication of both gram-positive and gram-negative ocular pathogens. Formulated with Moxifloxacin Hydrochloride IP (eq. Moxifloxacin 0.5% w/v) (0.5% w/v) in Sterile Ophthalmic Solution dosage form under Ophthalmic & Otic Care, manufactured to IP / BP / USP Compendial standards and supplied in 5 ml Sterile Opaque LDPE Dropper Bottle with Tamper-Evident Nozzle with complete eCTD/ACTD regulatory dossiers, Zone IVb stability, and batch CoA for African NRAs (NAFDAC, PPB, SAHPRA, TMDA, FDA Ghana) and global tenders.
| Item Code (SKU) | AKP-061 |
|---|---|
| Therapeutic Sector | Ophthalmic & Otic Care |
| Dosage Form | Sterile Ophthalmic Solution |
| Active Ingredient | Moxifloxacin Hydrochloride IP (eq. Moxifloxacin 0.5% w/v) |
| Strength / Purity | 0.5% w/v |
| Clinical Indication | Bacterial conjunctivitis, corneal ulceration, and post-cataract surgical endophthalmitis prophylaxis |
| Specification Standard | IP / BP / USP Compendial |
| Packaging Format | 5 ml Sterile Opaque LDPE Dropper Bottle with Tamper-Evident Nozzle |
| Shelf Life | 24–36 Months |
| Storage Conditions | Store below 25°C; use within 1 month of opening; do not touch dropper tip |
| Minimum Order Quantity | 1000 Packs |
| Regulatory / Analytical Docs | Full eCTD / ACTD Modules 1–5 + Zone IVb Stability Available |
| African & Global NRA Readiness | NAFDAC (Nigeria), PPB (Kenya), SAHPRA (SA), TMDA (Tanzania), FDA Ghana, AIRP, ARP, EFDA |
| Stock Availability | In Stock · Immediate Commercial Dispatch |
| Supply Status | Commercial Export Ready |